Compounds > fondaparinux

fondaparinux and Hemoglobinuria--Paroxysmal

fondaparinux has been researched along with Hemoglobinuria--Paroxysmal* in 2 studies

Other Studies

2 other study(ies) available for fondaparinux and Hemoglobinuria--Paroxysmal

ArticleYear
Paroxysmal nocturnal hemoglobinuria following alemtuzumab immunosuppressive therapy for myelodysplastic syndrome and complicated by recurrent life-threatening thrombosis despite anticoagulation: successful intervention with eculizumab and fondaparinux.
    Leukemia research, 2010, Volume: 34, Issue:4

    Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Anticoagulants; Fondaparinux; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Male; Middle Aged; Myelodysplastic Syndromes; Polypharmacy; Polysaccharides; Recurrence; Thrombosis; Treatment Outcome

2010
Successful use of Arixtra in a patient with paroxysmal nocturnal hemoglobinuria, Budd-Chiari syndrome and heparin-induced thrombocytopenia.
    Journal of thrombosis and haemostasis : JTH, 2003, Volume: 1, Issue:11

    Topics: Adult; Budd-Chiari Syndrome; Fondaparinux; Hemoglobinuria, Paroxysmal; Heparin; Humans; Male; Polysaccharides; Thrombocytopenia; Treatment Outcome

2003